EP1107740A4 - Timed release tablet comprising naproxen and pseudoephedrine - Google Patents
Timed release tablet comprising naproxen and pseudoephedrineInfo
- Publication number
- EP1107740A4 EP1107740A4 EP98941051A EP98941051A EP1107740A4 EP 1107740 A4 EP1107740 A4 EP 1107740A4 EP 98941051 A EP98941051 A EP 98941051A EP 98941051 A EP98941051 A EP 98941051A EP 1107740 A4 EP1107740 A4 EP 1107740A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pseudoephedrine
- naproxen
- release tablet
- timed release
- timed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1998/017625 WO2000010537A1 (en) | 1997-03-19 | 1998-08-25 | Timed release tablet comprising naproxen and pseudoephedrine |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1107740A1 EP1107740A1 (en) | 2001-06-20 |
EP1107740A4 true EP1107740A4 (en) | 2002-03-06 |
Family
ID=22267747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98941051A Withdrawn EP1107740A4 (en) | 1998-08-25 | 1998-08-25 | Timed release tablet comprising naproxen and pseudoephedrine |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1107740A4 (en) |
JP (1) | JP2002523358A (en) |
AU (1) | AU758880B2 (en) |
CA (1) | CA2341485A1 (en) |
MX (1) | MXPA01001969A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE544447T1 (en) * | 2003-09-26 | 2012-02-15 | Alza Corp | MEDICINAL COATING WITH A HIGH ACTIVE INGREDIENTS CONTENT AND METHODS FOR THE PRODUCTION THEREOF |
US10576041B2 (en) | 2016-09-26 | 2020-03-03 | The Procter & Gamble Company | Extended relief dosage form |
US11819482B2 (en) | 2017-08-29 | 2023-11-21 | Conrig Pharma Aps | Composition comprising suplatast tosilate |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992004022A1 (en) * | 1990-09-11 | 1992-03-19 | Richardson Vicks Inc. | Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders |
WO1995007103A1 (en) * | 1993-09-07 | 1995-03-16 | The Procter & Gamble Company | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
US5681582A (en) * | 1993-06-14 | 1997-10-28 | Janssen Pharmaceutica N.V. | Extended release, film-coated tablet of astemizole and pseudoephedrine |
EP0811374A1 (en) * | 1996-05-29 | 1997-12-10 | Pfizer Inc. | Combination dosage form comprising cetirizine and pseudoephedrine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5004613A (en) * | 1987-07-27 | 1991-04-02 | Mcneil-Ppc, Inc. | Oral sustained release pharmaceutical formulation and process |
US5073384A (en) * | 1989-10-19 | 1991-12-17 | Valentine Enterprises, Inc. | Maltodextrin/defoaming composition combinate |
-
1998
- 1998-08-25 AU AU89198/98A patent/AU758880B2/en not_active Ceased
- 1998-08-25 EP EP98941051A patent/EP1107740A4/en not_active Withdrawn
- 1998-08-25 CA CA002341485A patent/CA2341485A1/en not_active Abandoned
- 1998-08-25 JP JP2000565859A patent/JP2002523358A/en not_active Withdrawn
- 1998-08-25 MX MXPA01001969A patent/MXPA01001969A/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992004022A1 (en) * | 1990-09-11 | 1992-03-19 | Richardson Vicks Inc. | Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders |
US5681582A (en) * | 1993-06-14 | 1997-10-28 | Janssen Pharmaceutica N.V. | Extended release, film-coated tablet of astemizole and pseudoephedrine |
WO1995007103A1 (en) * | 1993-09-07 | 1995-03-16 | The Procter & Gamble Company | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
EP0811374A1 (en) * | 1996-05-29 | 1997-12-10 | Pfizer Inc. | Combination dosage form comprising cetirizine and pseudoephedrine |
Non-Patent Citations (1)
Title |
---|
See also references of WO0010537A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU758880B2 (en) | 2003-04-03 |
EP1107740A1 (en) | 2001-06-20 |
JP2002523358A (en) | 2002-07-30 |
MXPA01001969A (en) | 2002-04-24 |
CA2341485A1 (en) | 2000-03-02 |
AU8919898A (en) | 2000-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
IL141439A0 (en) | Immediate release tablet | |
HRP20060251B1 (en) | Substituted oxasolidinones and their use | |
IL120124A0 (en) | Heteroaryl-oxazolidinones their preparation and use | |
AU9015798A (en) | Local oral herbal slow release tablets | |
EP1070496A4 (en) | Tablet manufacturing method and tablet | |
HUP9700446A3 (en) | Oilsuspension-concentrate and using thereof | |
GB9702354D0 (en) | Compounds and their use | |
AU132520S (en) | Tablet | |
HUP0100192A3 (en) | Improved stomach-action molluscicides and preparation thereof | |
EP1070497A4 (en) | Tablet manufacturing methods and tablet | |
GB2352523B (en) | Fluid-gauging systems and methods | |
GB9725219D0 (en) | Tablets | |
HUP0104723A3 (en) | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use | |
EP1107740A4 (en) | Timed release tablet comprising naproxen and pseudoephedrine | |
PL328334A1 (en) | Preparation and application thereof | |
EP0998578A4 (en) | Sel-10 AND USES THEREOF | |
AU133610S (en) | Tablet | |
IL136514A0 (en) | Beta-lipotropin and uses thereof | |
ZA984896B (en) | Carbohydrates and use thereof | |
GB9902374D0 (en) | Food binder and holder | |
GB9904801D0 (en) | Message cube | |
GB9929581D0 (en) | Comjpositions and their use | |
IL146940A0 (en) | Novel calpains and their use | |
GB2341536B (en) | A rack and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010321 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020117 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 9/22 A, 7A 61K 9/32 B, 7A 61K 9/36 B, 7A 61K 31/137 B, 7A 61K 31/192 B |
|
17Q | First examination report despatched |
Effective date: 20020704 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030115 |